Skip to content
10-Q

Quarterly Report

Vivani Medical, Inc. VANI

0001753926-26-000852

← back to feed
Filed
May 13, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · May 12, 2026 86.24M sh
Shares Diluted Q1 2026 · Mar 31, 2026 81.27M sh
Shares Diluted Q1 2026 · Mar 31, 2025 59.24M sh
Capex Q1 2026 · Mar 31, 2026 $3K
Capex Q1 2026 · Mar 31, 2025 $5K
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$6.2M
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$5.16M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $19.75M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $16.23M
Stockholders Equity Q1 2026 · Mar 31, 2026 $19.09M
Stockholders Equity Q1 2026 · Dec 31, 2025 $15.73M
Stockholders Equity Q1 2026 · Mar 31, 2025 $11.62M
Stockholders Equity Q1 2026 · Dec 31, 2024 $17.61M
Current Liabilities Q1 2026 · Mar 31, 2026 $6.78M
Current Liabilities Q1 2026 · Dec 31, 2025 $6.6M
Total Liabilities Q1 2026 · Mar 31, 2026 $23.27M
Total Liabilities Q1 2026 · Dec 31, 2025 $23.66M
Current Assets Q1 2026 · Mar 31, 2026 $21.55M
Current Assets Q1 2026 · Dec 31, 2025 $17.9M
Total Assets Q1 2026 · Mar 31, 2026 $42.35M
Total Assets Q1 2026 · Dec 31, 2025 $39.39M
Eps Diluted Q1 2026 · Mar 31, 2026 −$0.08
Eps Diluted Q1 2026 · Mar 31, 2025 −$0.11
Eps Basic Q1 2026 · Mar 31, 2026 −$0.08
Eps Basic Q1 2026 · Mar 31, 2025 −$0.11
Sga Expense Q1 2026 · Mar 31, 2026 $2.43M
Sga Expense Q1 2026 · Mar 31, 2025 $2.34M
Rd Expense Q1 2026 · Mar 31, 2026 $4.39M
Rd Expense Q1 2026 · Mar 31, 2025 $4.22M
Net Income Q1 2026 · Mar 31, 2026 −$6.78M
Net Income Q1 2026 · Mar 31, 2025 −$6.3M
Operating Income Q1 2026 · Mar 31, 2026 −$6.82M
Operating Income Q1 2026 · Mar 31, 2025 −$6.56M